Palmoplantar Pustulosis Research Trial (20 weeks)

Adults aged 18 to less than 75 years with a physician-confirmed diagnosis of palmoplantar pustulosis (PPP) for at least 6 months, may qualify to participate. Eligible individuals must have moderate to severe disease, and show a lack of response or tolerability to local standard of care therapy for PPP or be contraindicated to such therapies.

Participants will receive investigational oral medication (active study drug) or placebo, in tablet form. Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses maybe provided.
 
Study participation will last about 20 weeks and involve about 7 visits to the study centre.
 
Call the study centre near you, or register now.
Learn more about
Palmoplantar Pustulosis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Similar Studies

  • At this time there are no other studies for this condition. Please register to be contacted about upcoming studies for this condition.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more